These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15704651)

  • 1. Angiogenesis measured by expression of CD34 antigen in lymph nodes of patients with non-Hodgkin's lymphoma.
    Mazur G; Wróbel T; Dziegiel P; Jeleń M; Kuliczkowski K; Zabel M
    Folia Histochem Cytobiol; 2004; 42(4):241-3. PubMed ID: 15704651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphometric angiogenesis parameters for indolent and aggressive non-Hodgkin's lymphoma.
    Kopic E; Cickusic E; Kopic A; Arnautovic-Custovic A; Halilbasic A; Tinjic L; Hasic S; Simendic V
    Med Arh; 2011; 65(1):9-12. PubMed ID: 21534443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Density of intranodal lymphatics and VEGF-C expression in B-cell lymphoma and reactive lymph nodes.
    Wróel T; Mazur G; Dziegiel P; Jeleń M; Szuba A; Kuliczkowski K; Zabel M
    Folia Histochem Cytobiol; 2006; 44(1):43-7. PubMed ID: 16584091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of tenascin is related to histologic malignancy and angiogenesis in b-cell non-Hodgkin's lymphomas.
    Vacca A; Ribatti D; Fanelli M; Costantino F; Nico B; Di Stefano R; Serio G; Dammacco F
    Leuk Lymphoma; 1996 Aug; 22(5-6):473-81. PubMed ID: 8882961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histomorphological and Morphometric Evaluation of Microvessel Density in Nodal Non-Hodgkin Lymphoma Using CD34 and CD105.
    ; Kataria SP; Malik S; Yadav R; Kapil R; Sen R
    J Lab Physicians; 2021 Mar; 13(1):22-28. PubMed ID: 34149231
    [No Abstract]   [Full Text] [Related]  

  • 6. Survivin expression in lymph nodes, affected by lymphoma and reactive hyperplasia.
    Mazur G; Haloń A; Wróbel T; Urbaniak J; Kuliczkowski K; Woźniak M
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():76-8. PubMed ID: 15638381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of Livin expression in non-Hodgkin's lymphoma].
    Gao JM; Wang X; Liu XQ; Ge XL; Ding M; Wang LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):385-90. PubMed ID: 20416174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?
    Ek ET; Ojaimi J; Kitagawa Y; Choong PF
    Oncol Rep; 2006 Jul; 16(1):17-23. PubMed ID: 16786118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased vascularization predicts favorable outcome in follicular lymphoma.
    Koster A; van Krieken JH; Mackenzie MA; Schraders M; Borm GF; van der Laak JA; Leenders W; Hebeda K; Raemaekers JM
    Clin Cancer Res; 2005 Jan; 11(1):154-61. PubMed ID: 15671540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis in Non-Hodgkin's Lymphoma: An Intercategory Comparison of Microvessel Density.
    Aggarwal D; Srivastava G; Gupta R; Pant L; Krishan G; Singh S
    ISRN Hematol; 2012; 2012():943089. PubMed ID: 22536524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The analysis of CD34 antigen immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases.
    Popiela TJ; Sikora J; Klimek M; Basta P; Niemiec T; Dobrogowski J; Kotlarz A; Rudnicka-Sosin L; Dutsch-Wicherek M
    Neuro Endocrinol Lett; 2008 Aug; 29(4):443-6. PubMed ID: 18766141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment.
    Kreuter M; Kropff M; Fischaleck A; Junker K; Gerss J; Heinecke A; Lindermann M; Reinmuth N; Berdel WE; Mesters RM; Thomas M
    Eur Respir J; 2009 Jun; 33(6):1383-8. PubMed ID: 19213790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIB1 (Ki-67) expression in non-Hodgkin's lymphomas.
    Kalogeraki A; Tzardi M; Panagiotides I; Koutsoubi K; Bolioti S; Rontogianni D; Stefanaki K; Zois E; Karidi E; Darivianaki K; Delides G; Kanavaros P
    Anticancer Res; 1997; 17(1A):487-91. PubMed ID: 9066700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage/histiocytic antigen CD68 expression in neoplastic and reactive lymph nodes.
    Mazur G; Haloń A; Wróbel T; Kuliczkowski K
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():73-5. PubMed ID: 15638380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial area and microvascular density in a canine non-Hodgkin's lymphoma: an interspecies model of tumor angiogenesis.
    Ranieri G; Patruno R; Lionetti A; Di Summa A; Mattioli E; Bufo P; Pellecchia A; Ribatti D; Zizzo N
    Leuk Lymphoma; 2005 Nov; 46(11):1639-43. PubMed ID: 16236617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications.
    Korkolopoulou P; Thymara I; Kavantzas N; Vassilakopoulos TP; Angelopoulou MK; Kokoris SI; Dimitriadou EM; Siakantaris MP; Anargyrou K; Panayiotidis P; Tsenga A; Androulaki A; Doussis-Anagnostopoulou IA; Patsouris E; Pangalis GA
    Leukemia; 2005 Jun; 19(6):894-900. PubMed ID: 15800675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma.
    Ruan J; Hyjek E; Kermani P; Christos PJ; Hooper AT; Coleman M; Hempstead B; Leonard JP; Chadburn A; Rafii S
    Clin Cancer Res; 2006 Oct; 12(19):5622-31. PubMed ID: 17020964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma.
    Bedewy AM; Elgammal MM; Bedewy MM; El-Maghraby SM
    Ann Hematol; 2013 Oct; 92(10):1359-67. PubMed ID: 23652586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological Evaluation of Angiogenic Markers in Non-Hodgkin's Lymphoma.
    Singh P; Tahlan A; Mohan H; Singh R
    J Lab Physicians; 2023 Jun; 15(2):282-288. PubMed ID: 37323605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.